VICTORY CAPITAL MANAGEMENT INC - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 5 filers reported holding INTELLIA THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
VICTORY CAPITAL MANAGEMENT INC ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$863,732
-21.1%
27,316
+1.8%
0.00%0.0%
Q2 2023$1,094,780
+8.6%
26,846
-0.8%
0.00%0.0%
Q1 2023$1,008,377
+14.3%
27,056
+7.0%
0.00%0.0%
Q4 2022$882,543
-38.9%
25,295
-2.1%
0.00%
-50.0%
Q3 2022$1,445,000
-1.2%
25,828
-8.6%
0.00%0.0%
Q2 2022$1,463,000
-96.5%
28,265
-95.2%
0.00%
-95.2%
Q1 2022$42,017,000
-43.4%
587,931
-6.3%
0.04%
-38.2%
Q4 2021$74,195,000
-28.1%
627,497
-18.4%
0.07%
-32.7%
Q3 2021$103,222,000
+62.0%
769,456
+95.5%
0.10%
+65.6%
Q2 2021$63,715,000
+1880.0%
393,523
+881.5%
0.06%
+1933.3%
Q1 2021$3,218,000
+66.2%
40,095
+12.7%
0.00%
+50.0%
Q4 2020$1,936,000
+160.6%
35,592
-4.8%
0.00%
+100.0%
Q3 2020$743,000
+462.9%
37,385
+244.7%
0.00%
Q1 2020$132,000
+5.6%
10,846
+27.4%
0.00%
Q4 2019$125,000
+86.6%
8,514
+69.6%
0.00%
Q3 2019$67,0005,0210.00%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Darwin Global Management, Ltd. 752,024$100,884,00018.57%
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. 420,859$56,458,0004.40%
Discovery Value Fund 922,411$123,741,0003.63%
MPM BioImpact LLC 162,620$21,815,0003.38%
Ally Bridge Group (NY) LLC 65,000$8,720,0002.56%
ARK Investment Management 6,743,556$904,648,0002.17%
Integral Health Asset Management, LLC 50,000$6,708,0001.93%
Yorktown Management & Research Co Inc 18,300$2,455,0001.85%
Interchange Capital Partners, LLC 8,191$1,098,0001.84%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 111,440$14,950,0001.76%
View complete list of INTELLIA THERAPEUTICS INC shareholders